Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Francesca Canta is active.

Publication


Featured researches published by Francesca Canta.


Infection | 2007

Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients.

F. G. De Rosa; Stefania Cicalini; Francesca Canta; Sabrina Audagnotto; Enrico Cecchi; G. Di Perri

Background:Intravenous drug users (IDUs) are at increased risk of infective endocarditis (IE).Patients and Methods:Episodes of IE in IDUs were retrospectively analyzed in this multicenter study. Cases were collected between 1986 and 1999. Only definite diagnosis according to the Duke criteria were analyzed.Results:Two hundred and sixty-three cases, including 100 cases in HIV-positive patients, were observed in IDUs. Any right-sided involvement was detected in 167 out of 263 cases (63.5%) and any left-sided involvement in 115 out of 263 cases (43.7%). The tricuspid valve (TV) alone was affected in 135 cases (51.3%), the mitral valve alone in 32 patients (12.1%), the aortic valve alone in 41 cases (15.6%) and the pulmonic valve alone in 3 cases. Staphylococcus aureus was isolated in 156 cases (59.3%) and Streptococcus spp. in 33 cases (12.5%). No major differences were observed between HIV-negative and HIV-positive patients. Any TV valve involvement was significantly associated with female rather than male gender (p = 0.02). There was a significant association between S. aureus etiology and TV involvement (p < 0.0001). The mortality rate was 16%. On multivariate analysis, only left-side IE (p = 0.0006; OR 5.2; 95% CI 2.0–13.5) and age greater than 35 years (p = 0.0068; OR 3.6; 95% CI 1.4–9.0) were independently associated with mortality.Conclusions:Infective endocarditis in IDUs is significantly associated with right-side localization (63.5% for any rightsided heart involvement vs 43.7% for any left-sided heart involvement; OR 2.24; 95% CI 1.55–3.23; p < 0.001). S. aureus is the microorganism most frequently isolated and is significantly associated with TV involvement. Any left-side involvement and age greater than 35 years are independently associated with mortality. HIV infection does not appear to have a significant effect on mortality.


International Journal of Cardiology | 2015

Clinical epidemiology in Italian Registry of Infective Endocarditis (RIEI): Focus on age, intravascular devices and enterococci.

Enrico Cecchi; Fabio Chirillo; Anna Castiglione; Pompilio Faggiano; Moreno Cecconi; Antonella Moreo; Alessandro Cialfi; Mauro Rinaldi; Stefano del Ponte; Angelo Squeri; Silvia Corcione; Francesca Canta; Oscar Gaddi; Francesco Enia; Davide Forno; Piera Costanzo; Alfredo Zuppiroli; Flavio Bologna; Anna Patrignani; Riccardo Belli; Giovannino Ciccone; Francesco Giuseppe De Rosa

INTRODUCTION The epidemiology of infective endocarditis (IE) is changing due to a number of factors, including aging and health related comorbidities and medical procedures. The aim of this study is to describe the main clinical, epidemiologic and etiologic changes of IE from a large database in Italy. METHODS We prospectively collected episodes of IE in 17 Italian centers from July 2007 to December 2010. RESULTS We enrolled 677 patients with definite IE, of which 24% health-care associated. Patients were male (73%) with a median age of 62 years (IQR: 49-74) and 61% had several comorbidities. One hundred and twenty-eight (19%) patients had prosthetic left side IE, 391 (58%) native left side IE, 94 (14%) device-related IE and 54 (8%) right side IE. A predisposing cardiopathy was present in 50%, while odontoiatric and non odontoiatric procedures were reported in 5% and 21% of patients respectively. Symptoms were usually atypical and precocious. The prevalent etiology was represented by Staphylococcus aureus (27%) followed by coagulase-negative staphylococci (CNS, 21%), Streptococcus viridans (15%) and enterococci (14%). CNS and enterococci were relatively more frequent in patients with intravascular devices and prosthesis and S. viridans in left native valve. Diagnosis was made by transthoracic and transesophageal echocardiography in 62% and 94% of cases, respectively. The in-hospital mortality was 14% and 1-year mortality was 21%. CONCLUSION The epidemiology is changing in Italy, where IE more often affects older patients with comorbidities and intravascular devices, with an acute onset and including a high frequency of enterococci. There were few preceding odontoiatric procedures.


Journal of Travel Medicine | 2006

Puumala virus pulmonary syndrome in a Romanian immigrant

Pietro Caramello; Francesca Canta; Lodovica Bonino; Corrado Moiraghi; Fabrizia Navone; Filippo Lipani; Rosanna Balbiano; Anna Maria Caputo; Valerio Gai

Hantaviruses belong to the Bunyaviridae family, which is comprised of Bunyavirus, Phlebovirus, Nairovirus, and Hantavirus. Euroasiatic Hantaviruses belong to two distinct subfamilies: Murinae (comprising Hantaan, Dobrava, and Seoul viruses), which are responsible for hemorrhagic fever with renal syndrome (HFRS), and Arvicolinae (comprising Puumala virus), responsible for nephropathia epidemica (NE) and HFRS. On the contrary, the New World Hantavirus belongs to the Sigmodontinae subfamily and includes the North American viruses: Sin Nombre, Monongahela; New York, Bayou, Black Creek Canal, and the South American, which comprise the Andes, Oran, Lechiguanas, Laguna Negra, Juquitiba; both groups are responsible for the hantavirus pulmonary syndrome (HPS).


Journal of Travel Medicine | 2006

Pharmacodynamic Analysis of Antimalarials Used in Plasmodium falciparum Imported Malaria in Northern Italy

Pietro Caramello; Francesca Canta; Ilaria Cavecchia; Giuseppina Sergi; Filippo Lipani; Guido Calleri; Federico Gobbi; Giovanni Di Perri

BACKGROUND Conventional treatment of imported malaria in Italy consists of quinine or mefloquine. Since beta-arthemeter is now available, an open-label pharmacodynamic analysis was performed in 73 adults with uncomplicated Plasmodium falciparum malaria. In vitro susceptibility to mefloquine and quinine was evaluated at admission. METHODS According to clinical status, baseline parasitemia (P(0)), and premunition, the patients received intravenous quinine, oral mefloquine, or beta-arthemeter. The following parameters were measured: parasitemia at 0, 6, 12, and 24 hours and then every 24 hours until negative; time to 50%, 90%, and 100% reduction in parasite density (PC(50), PC(90), and PCT); parasite reduction ratio at 24 and 48 hours (PRR(24) and PRR(48)); percentage of patients with undetectable parasitemia at 48 hours (PPUP(48)); time required to eradication; in vitro susceptibility to mefloquine and quinine by World Health Organization Microtest Mark III. RESULTS Of the study patients, 54.8% were immigrants from malaria-endemic countries. All the infections were acquired in Africa. All the patients were treated successfully. According to the pharmacodynamic parameters measured, no significant differences were recorded among patients with or without prior exposure to malaria. Pharmacodynamic comparison was performed between quinine and beta-arthemeter. Significantly higher clearance times were recorded for beta-arthemeter vs quinine (PC(50), PC(90), and PCT: 16.8, 42.6, and 72 h for quinine vs 7.9, 12.2, and 48 h for beta-arthemeter; p values: .02, < .0001, and .008, respectively). The number of patients who obtained a PPUP(48) with beta-arthemeter was higher than with quinine (66.7 vs 9.1%, p < .003), and PRR(24) was significantly higher in beta-arthemeter-treated patients (617 vs 3.15, p = .0001). PRR(48) and time to eradication were not measurable in the beta-arthemeter group (negative P at 48 h in most cases). Two recrudescences occurred after 5 and 7 days of beta-arthemeter monotherapy. All strains were fully susceptible to quinine and mefloquine. CONCLUSIONS Pharmacodynamic properties of mefloquine and quinine are in the range reported in literature. The better PCT and pharmacodynamics of beta-arthemeter suggest that it could be used as a first-line agent, coadministered with mefloquine.


Travel Medicine and Infectious Disease | 2008

Klebsiella pneumoniae meningitis in a 38-year-old Chinese traveller with impaired glucose tolerance: A new emerging syndrome?

Lucio Boglione; Claudia Spezia; Filippo Lipani; Rosanna Balbiano; Francesca Canta; Rosalia Marrone; Maura De Agostini; Guido Calleri; Pietro Caramello

Early diagnosis and appropriate empirical treatment of bacterial meningitis reduce morbidity and mortality. Prevalence rates of different causative pathogens associated with bacterial meningitis can depend on age, the underlying medical condition, way of infection and geographical distribution. Klebsiella pneumoniae represents an infrequent cause of community-acquired meningitis in South-East Asia and North-East Asia, where it accounts for 20% of all bacterial meningitis, frequently associated with septic metastatic complications. We describe a case of K. pneumoniae meningitis, diplopia and chemosis in a recently immigrated patient with impaired glucose tolerance. The reason for the high prevalence of metastatic septic infections caused by K. pneumoniae in Taiwan and South-East Asia remains unclear: high prevalence in this area of serotype K1 and K2 and the expression of a novel locus called magA conferring to bacterium an elevated phagocytosis resistance and an active proliferation ability have been suggested. A high degree of suspicion for this etiology must be taken into account in immigrants from China and Taiwan. Due to a very high lethality, guidelines on empiric treatment should be considered in the management of bacterial meningitis, with the patients geographical origin and the clinical syndrome (meningitis and endophtalmitis) as potential risk factors for K. pneumoniae infection.


Emerging Infectious Diseases | 2007

Imported Chikungunya infection, Italy.

Anna Beltrame; Andrea Angheben; Zeno Bisoffi; Geraldo Badona Monteiro; Stefania Marocco; Guido Calleri; Filippo Lipani; Federico Gobbi; Francesca Canta; Francesco Castelli; Maurizio Gulletta; Sara Bigoni; Veronica Del Punta; Tiziana Iacovazzi; Roberto Romi; Loredana Nicoletti; Maria Grazia Ciufolini; Giada Rorato; Camilla Negri; Pierluigi Viale


Journal of Antimicrobial Chemotherapy | 2005

Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients

Francesca Canta; R. Marrone; Stefano Bonora; Antonio D'Avolio; Mauro Sciandra; Alessandro Sinicco; F. G. De Rosa; G. Di Perri


Infection, Genetics and Evolution | 2006

Prevalence of pfcrt point mutations and level of chloroquine resistance in Plasmodium falciparum isolates from Africa

Carlo Severini; Michela Menegon; Anna Rosa Sannella; Maria Grazia Paglia; Pasquale Narciso; Alberto Matteelli; Maurizio Gulletta; Pietro Caramello; Francesca Canta; Maniphet Xayavong; Iaci N.S. Moura; Norman J. Pieniazek; Donatella Taramelli; Giancarlo Majori


Clinical Infectious Diseases | 2006

Role of Intravenous Immunoglobulin Administration in Japanese Encephalitis

Pietro Caramello; Francesca Canta; Rosanna Balbiano; Filippo Lipani; Silvia Ariaudo; Maura De Agostini; Guido Calleri; Lucio Boglione; Antonino Di Caro


Journal of Travel Medicine | 2007

A case of imported JE acquired during short travel in Vietnam. Are current recommendations about vaccination broader

Pietro Caramello; Francesca Canta; Rosanna Balbiano; Filippo Lipani; Silvia Ariaudo; Maura De Agostini; Guido Calleri; Lucio Boglione; Antonino Di Caro

Collaboration


Dive into the Francesca Canta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge